Document:

Prepared by MERRILL CORPORATION

QuickLinks
 -- Click here to rapidly navigate through this document
  

Exhibit 10.8  

 
 

SECURITIES PURCHASE AGREEMENT    
  

        This
SECURITIES PURCHASE AGREEMENT is dated as of January 22, 2002 by and among TRIPATH TECHNOLOGY, INC., a Delaware corporation with its principal office at 3900 Freedom
Circle, Santa Clara, California, 95054 (the "Company"), and the persons listed as Purchasers on the signature page and on Exhibit A hereto (the "Purchasers"). 

        WHEREAS,
the Company desires to issue and sell to the Purchasers units ("Units"), each Unit consisting of one (1) share (the "Shares") of the authorized but unissued
Series A Preferred Stock, $0.001 par value per share, of the Company (the "Series A Preferred Stock") and a Series A Preferred Stock purchase warrant ("Warrants") representing the
right to purchase .20 of a share of Series A Preferred Stock (collectively, the "Warrant Shares"); and 

        WHEREAS,
each Purchaser wishes to purchase the Units on the terms and subject to the conditions set forth in this Agreement. 

        NOW
THEREFORE, in consideration of the mutual agreements, representations, warranties and covenants herein contained, the parties hereto agree as follows: 

        1.    Definitions.
As used in this Agreement, the following terms shall have the following respective meanings: 

        (a)  "Affiliate"
of a party, means any corporation or other business entity controlled by, controlling or under common control with such party. For this purpose "control"
shall mean direct or indirect beneficial ownership of fifty percent (50%) or more of the voting or income interest in such corporation or other business entity. 

        (b)  "Closing
Date" means the date of the Closing. 

        (c)  "Exchange
Act" means the Securities Exchange Act of 1934, as amended, and all of the rules and regulations promulgated there under. 

        (d)  "Initial
Closing Date" means the date of the Initial Closing. 

        (d)  "Registration
Rights Agreement" shall mean that certain Registration Rights Agreement, dated as of the date hereof, among the Company and the Purchasers. 

        (e)  "SEC"
shall mean the Securities and Exchange Commission. 

        (f)    "Securities
Act" shall mean the Securities Act of 1933, as amended, and all of the rules and regulations promulgated there under. 

        2.    Purchase
and Sale of Units 

        2.1    Purchase and Sale.    Subject to and upon the terms and conditions set forth in this Agreement, the Company
agrees to issue and sell to the Purchasers severally and not jointly, and each Purchaser hereby agrees to purchase from the Company severally and not jointly, at the Closing, the number of Units set
forth opposite the name of the Purchaser under the heading "Number of Units to be Purchased" on Exhibit A hereto, at a purchase price per Unit of $30.00. In addition, the Company shall issue
Warrants to the Holders representing the right to purchase that number of shares of Series A Preferred Stock equal to twenty percent (20%) of that number of shares of Series A Preferred
Stock purchased by the Holder as listed on Exhibit A as described above. The exercise price for each Warrant shall be $39.00 per share of Series A Preferred Stock. The total purchase
price payable by each Purchaser for the number of Units that the Purchaser is hereby purchasing is set forth on Exhibit A hereto. The Series A Preferred Stock will have the 

1

 

rights, preferences, privileges and restrictions set forth in the Certificate of Designations filed as part of the Certificate of Incorporation of the Company establishing the rights, preferences and
privileges of the Series A Preferred Stock and which is attached hereto as Schedule 2.1, and the Warrants shall have such terms as set
forth in Exhibit B attached hereto. 

        2.2    Closing.    The initial closing (the "Initial Closing") and any additional any closing subsequent to the
Initial Closing (each a "Subsequent Closing," and together with the Initial Closing, each a "Closing") of the transactions contemplated under this Agreement shall take place upon receipt of a wire
transfer or other form of payment in same day funds from each Purchaser of the amount of the purchase price to the escrow account established by Emerging Growth Equities, Ltd. (the "Placement
Agent") at First Union National Bank as escrow agent (the "Escrow Agent") pursuant to the terms of the escrow agreement among the Company, the Placement Agent and the Escrow Agent, together with an
executed copy of this Agreement. The purchase and sale of the Units shall take place at the offices of Gray Cary Ware & Freidenrich LLP, 400 Hamilton Avenue, Palo Alto, CA
94301-1833, and the acceptance by the Company of the Purchaser's purchase of Units. Within three business days of the Closing, the Company shall deliver to each Purchaser a single stock
certificate and a single warrant certificate in the form attached hereto as Exhibit B, each registered in the name of the Purchaser, representing the number of shares of Series A
Preferred Stock and Warrants purchased by the Purchaser, as computed pursuant to Section 2.1 hereof. 

        3.    Representations
and Warranties of the Company. The Company hereby represents and warrants to the Purchasers as of the Closing Date as follows: 

        3.1    Incorporation.    The Company is a corporation duly organized, validly existing and in good standing under the
laws of the State of Delaware and is qualified to do business in each jurisdiction in which the character of its properties or the nature of its business requires such qualification, except where the
failure to so qualify would not have a material adverse effect upon the Company. The Company has all requisite corporate power and authority to carry on its business as now conducted. 

        3.2    Capitalization.    The authorized capital stock of the Company consists of 100,000,000 shares of Common Stock,
par value of $0.001, of which 27,231,988 shares were outstanding as of November 30, 2001 and 5,000,000 shares of Preferred Stock, par value of $0.001, 865,200 of which have been designated
Series A Preferred Stock, of which no shares are outstanding on the date hereof. Except as set forth in Schedule 3.2 hereto, there are no existing options, warrants, calls, preemptive
(or similar) rights, subscriptions or other rights, agreements, arrangements or commitments of any character obligating the Company to issue, transfer or sell, or cause to be issued, transferred or
sold, any shares of the capital stock of the Company or other equity interests in the Company or any securities convertible into or exchangeable for such shares of capital stock or other equity
interests, and there are no outstanding contractual obligations of the Company to repurchase, redeem or otherwise acquire any shares of its capital stock or other equity interests. 

        3.3    Authorization.    All corporate action on the part of the Company and its officers, directors and stockholders
necessary for the authorization, execution, delivery and performance of this Agreement and the Registration Rights Agreement and the consummation of the transactions contemplated herein
and therein has been taken. When executed and delivered by the Company, each of this Agreement and the Registration Rights Agreement shall constitute the legal, valid and binding obligation of the
Company, enforceable against the Company in accordance with its terms, except as such may be limited by bankruptcy, insolvency, reorganization or other laws affecting creditors' rights generally and
by general equitable principles. The Company has all requisite corporate power to enter into this Agreement and the Registration Rights Agreement and to carry 

2

 

out and perform its obligations under the terms of this Agreement and the Registration Rights Agreement. 

        3.4    Valid Issuance of the Units.    The Shares and the Warrant Shares being purchased by the Purchasers hereunder
will, upon issuance pursuant to the terms hereof and thereof, be duly authorized and validly issued, fully paid and nonassessable and have been duly reserved for issuance. 

        3.5    Offering.    No form of general solicitation or general advertising was used by the Company or its
representatives in connection with the offer, sale or issuance of the Shares and the Warrants. In reliance on the representations and warranties of the Purchasers in Section 4 hereof, the
offer, sale and issuance of the Shares and the Warrants in conformity with the terms of this Agreement will not result in a violation of the requirements of Section 5 of the Securities Act of
1933, as amended. 

        3.6    Financial Statements.    The Company has made available to the Purchasers its audited Statements of Operations,
Stockholders' Equity and Cash Flows for the fiscal year ended December 31, 2000, its audited Balance Sheet as of December 31, 2000, and its unaudited Statements of Operations,
Stockholders' Equity and Cash Flows for the nine months ended September 30, 2001 and its unaudited Balance Sheet as of September 30, 2001. All such financial statements are hereinafter
referred to collectively as the "Financial Statements." The Financial Statements have been prepared in accordance with generally accepted accounting principles applied on a consistent basis during the
periods involved, and fairly present, in all material respects, the financial position of the Company and the results of its operations as of the date and for the periods indicated thereon, except
that the unaudited financial statements may not be in accordance with generally accepted accounting principles because of the absence of footnotes normally contained therein and are subject to normal
year-end audit adjustments which, individually and in the aggregate, will not be material. Since September 30, 2001, to the Company's knowledge, there has been no material adverse
change (actual or threatened) in the assets, liabilities (contingent or other), affairs, operations, prospects or condition (financial or other) of the Company. Notwithstanding anything to the
contrary in this Agreement, the Company's current financial performance may vary materially from expectations disclosed in the Company's SEC Documents (as such term is defined below) and other
publicly released information by the Company due to corporate response to recent market volatility and uncertainty in the Company's markets. 

        3.7    SEC Documents.    The Company has informed the Purchasers of the accessibility of the following documents on
www.sec.gov: the Company's Annual Report on Form 10-K for the year ended December 31, 2000, the Company's Quarterly Report on Form 10-Q for the nine months
ended September 30, 2001, and any other statement, report, registration statement (other than registration statements on Form S-8) or definitive proxy statement filed by the
Company with the SEC during the
period commencing December 31, 2000, and ending on the date hereof (all such materials being called, collectively, the "SEC Documents"). As of their respective filing dates, the SEC Documents
complied in all material respects with the requirements of the Exchange Act or the Securities Act, as applicable, and none of the SEC Documents contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading, as
of their respective filing dates, except to the extent corrected by a subsequently filed SEC Document. 

        3.8    Consents.    All consents, approvals, orders and authorizations required on the part of the Company in
connection with the execution, delivery or performance of this Agreement and the Registration Rights Agreement and the consummation of the transactions contemplated herein, 

3

 

other than for Regulation D and state blue sky filings with respect to the sale of Units which will be made post-closing in accordance with such laws, and therein have been
obtained and will be effective as of the Closing Date. 

        3.9    No Conflict.    The execution and delivery of this Agreement and the Registration Rights Agreement by the
Company and the consummation of the transactions contemplated hereby and thereby will not conflict with or result in any violation of or default (with or without notice or lapse of time, or both)
under, or give rise to a right of termination, cancellation or acceleration of any obligation or to a loss of a material benefit under (i) any provision of the Certificate of Incorporation or
Bylaws of the Company or (ii) any agreement or instrument, permit, franchise, license, judgment, order, statute, law, ordinance, rule or regulations, applicable to the Company or its properties
or assets. 

        3.10    Placement Agent.    In consideration for services rendered by the Placement Agent in placing the Units, the
Company has agreed to pay the Placement Agent an aggregate commission consisting of (i) a cash payment equal to five percent (5%) of the gross proceeds of the sale of the Units sold under this
Securities Purchase Agreement and (ii) an option to purchase that number of Units equal to three percent (3%) of the Units sold under this Securities Purchase Agreement at an exercise price
equal to $30.00 per Unit. Other than as set forth herein, the Company has no obligation to pay brokers' fees or commissions by virtue of the sale of the Units. 

        3.11    NASDAQ National Market.    The Company's Common Stock is listed on the NASDAQ National Market System, and
there are no proceedings to revoke or suspend such listing and the Company has not received any communication from the NASDAQ National Market System with respect to any pending or threatened
proceeding that would give rise to a delisting. After obtaining the approval of the Company's stockholders to the issuance of the Common Stock issuable upon conversion of the Series A Preferred
Stock (the "Approval"), the Company shall apply for the listing of the Common Stock issuable upon conversion of the Series A Preferred Stock and upon conversion of the Series A Preferred
Stock issuable upon conversion of the Warrant Shares, on the NASDAQ National Market System, if required by NASDAQ. 

        3.12    Absence of Litigation.    There is no action, suit or proceeding or, to the Company's knowledge, any
investigation, pending or threatened by or before any governmental body against the Company and in which an unfavorable outcome, ruling or finding in any said matter, or for all matters taken as a
whole, might have a material adverse effect on the Company. The foregoing includes, without limitation, any such action, suit, proceeding or investigation that questions this Agreement or the
Registration Rights Agreement or the right of the Company to execute, deliver and perform under same. 

        4.    Representations
and Warranties of the Purchasers. Each Purchaser, severally and not jointly, represents and warrants to the Company as of the Closing Date as follows: 

        4.1    Authorization.    All action on the part of the Purchaser and, if applicable, its officers, directors and
shareholders necessary for the authorization, execution, delivery and performance of this Agreement and the Registration Rights Agreement and the consummation of the transactions contemplated herein
and therein has been taken. When executed and delivered, each of this Agreement and the Registration Rights Agreement will constitute the legal, valid and binding obligation of the Purchaser,
enforceable against the Purchaser in accordance with its terms, except as such may be limited by bankruptcy, insolvency, reorganization or other laws affecting creditors' rights generally and by
general equitable principles. The Purchaser has all requisite power or corporate power, whichever is applicable, to enter into each of this Agreement and the Registration Rights Agreement and to carry
out and perform its obligations under the terms of this Agreement and the Registration Rights Agreement. 

4

 

        4.2    Purchase Entirely for Own Account.    The Purchaser is acquiring the Units being purchased by it hereunder for
investment, for its own account, and not for resale or with a view to distribution thereof in violation of the Securities Act. 

        4.3    Investor Status; Etc.    The Purchaser certifies and represents to the Company that at the time the Purchaser
acquires any of the Units, the Purchaser will be an "Accredited Investor" as defined in Rule 501 of Regulation D promulgated under the Securities Act and was not organized for the
purpose of acquiring the Units. The Purchaser's financial condition is such that it is able to bear the risk of holding the Units for an indefinite period of time and the risk of loss of its entire
investment. The Purchaser has been afforded the opportunity to ask questions of and receive answers from the management of the Company concerning this investment and has sufficient knowledge and
experience in investing in companies similar to the Company in terms of the Company's stage of development so as to be able to evaluate the risks and merits of its investment in the Company. 

        4.4    Units Not Registered.    The Purchaser understands that the Units and the securities that make up the Units
have not been registered under the Securities Act, by reason of their issuance by the Company in a transaction exempt from the registration requirements of the Securities Act, and that the Units must
continue to be held by the Purchaser unless a subsequent disposition thereof is registered under the Securities Act or is exempt from such registration. The Purchaser understands that the exemptions
from registration afforded by Rule 144 (the provisions of which are known to it) promulgated under the Securities Act depend on the satisfaction of various conditions, and that, if applicable,
Rule 144 may afford the basis for sales only in limited amounts. 

        4.5    No Conflict.    The execution and delivery of this Agreement and the Registration Rights Agreement by the
Purchaser and the consummation of the transactions contemplated hereby and thereby will not conflict with or result in any violation of or default by the Purchaser (with or without notice or lapse of
time, or both) under, or give rise to a right of termination, cancellation or acceleration of any obligation or to a loss of a material benefit under (i) any provision of the organizational
documents of the Purchaser or (ii) any agreement or instrument, permit, franchise, license, judgment, order, statute, law, ordinance, rule or regulations, applicable to the Purchaser or its
properties or assets. 

        4.6    Consents.    All consents, approvals, orders and authorizations required on the part of the Purchaser in
connection with the execution, delivery or performance of this Agreement and the consummation of the transactions contemplated herein have been obtained and are effective as of the Closing Date. 

        4.7    Escrow Agreement.    In connection with and in consideration of this Agreement, each Purchaser hereby adopts
and agrees to be bound by the terms and conditions of the Escrow Agreement (the "Escrow Agreement"), dated as of January 22, 2002, by and between the Company, the Escrow Agent and the Placement
Agent in the form attached hereto as Exhibit C, as if the Purchaser had executed such Escrow Agreement. 

        5.    Conditions
Precedent. 

        5.1.  Conditions
to the Obligation of the Purchasers to Consummate the Closing. The obligation of the Purchasers to consummate the Closing and to purchase and pay for the
Units being purchased by it pursuant to this Agreement is subject to the satisfaction of the following conditions precedent: 

	(a)
	The
representations and warranties contained herein of the Company shall be true and correct on and as of the Closing Date with the same force and effect as though made on and as of
the Closing Date (it being understood and agreed by the Purchasers that, in the case of any representation and warranty of the Company contained herein which is not 

5

 

hereinabove
qualified by application thereto of a materiality standard, such representation and warranty need be true and correct only in all material respects in order to satisfy as to such
representation or warranty the condition precedent set forth in the foregoing provisions of this Section 5.1(a)). 

	(b)
	The
Registration Rights Agreement shall have been executed and delivered by the Company.

	(c)
	The
Company shall have performed all obligations and conditions herein required to be performed or observed by the Company on or prior to the Closing Date.

	(d)
	No
proceeding challenging this Agreement or the transactions contemplated hereby, or seeking to prohibit, alter, prevent or materially delay the Closing, shall have been instituted
before any court, arbitrator or governmental body, agency or official and shall be pending.

	(e)
	The
purchase of and payment for the Units by the Purchasers shall not be prohibited by any law or governmental order or regulation. All necessary consents, approvals, licenses,
permits, orders and authorizations of, or registrations, declarations and filings with, any governmental or administrative agency or of any other person with respect to any of the transactions
contemplated hereby, other than for Regulation D and state blue sky filings with respect to the sale of the Units, shall have been duly obtained or made and shall be in full force and effect.

	(f)
	All
instruments and corporate proceedings in connection with the transactions contemplated by this Agreement to be consummated at the Closing shall be satisfactory in form and
substance to the Purchasers, and the Purchasers shall have received copies (executed or certified, as may be appropriate) of all documents which the Purchasers may have reasonably requested in
connection with such transactions. 

        5.2.  Conditions
to the Obligation of the Company to Consummate the Closing. The obligation of the Company to consummate the Closing and to issue and sell to the Purchasers
the Units to be purchased at the Closing is subject to the satisfaction of the following conditions precedent: 

	(a)
	The
representations and warranties contained herein of each Purchaser shall be true and correct on and as of the Closing Date with the same force and effect as though made on and as
of the Closing Date (it being understood and agreed by the Company that, in the case of any representation and warranty of a Purchaser contained herein which is not hereinabove qualified by
application thereto of a materiality standard, such representation and warranty need be true and correct only in all material respects in order to satisfy as to such representation or warranty the
condition precedent set forth in the foregoing provisions of this Section 5.2(a)).

	(b)
	The
Registration Rights Agreement shall have been executed and delivered by the Purchasers.

	(c)
	The
Purchasers shall have performed all obligations and conditions herein required to be performed or observed by the Purchasers on or prior to the Closing Date.

	(d)
	No
proceeding challenging this Agreement or the transactions contemplated hereby, or seeking to prohibit, alter, prevent or materially delay the Closing, shall have been instituted
before any court, arbitrator or governmental body, agency or official and shall be pending.

	(e)
	The
sale of the Units by the Company shall not be prohibited by any law or governmental order or regulation. All necessary consents, approvals, licenses, permits, orders and 

6

 

authorizations
of, or registrations, declarations and filings with, any governmental or administrative agency or of any other person with respect to any of the transactions contemplated hereby, other
than for Regulation D and state blue sky filings with respect to the sale of the Units, shall have been duly obtained or made and shall be in full force and effect. 

	(f)
	All
instruments and corporate proceedings in connection with the transactions contemplated by this Agreement to be consummated at the Closing shall be satisfactory in form and
substance to the Company, and the Company shall have received counterpart originals, or certified or other copies of all documents, including without limitation records of corporate or other
proceedings, which it may have reasonably requested in connection therewith. 

        6.    Transfer,
Legends. 

        6.1.    Securities Law Transfer Restrictions.    The Purchasers shall not sell, assign, pledge, transfer or otherwise
dispose or encumber any of the Units being purchased by it hereunder, except (i) pursuant to an effective registration statement under the Securities Act or (ii) pursuant to an available
exemption from registration under the Securities Act and applicable state securities laws and, if requested by the Company, upon delivery by the Purchaser of an opinion of counsel reasonably
satisfactory to the Company to the effect that the proposed transfer is exempt from registration under the Securities Act and applicable state securities laws. Any transfer or purported transfer of
the Units in violation of this Section 6.1 shall be voidable by the Company. The Company shall not register any transfer of the Units in violation of this Section 6.1. The Company may,
and may instruct any transfer agent for the Company, to place such stop transfer orders as may be required on the transfer books of the Company in order to ensure compliance with the provisions of
this Section 6.1. 

        6.2.    Legends.    Each certificate representing any of the Shares or the Warrant Shares shall be endorsed with the
legend set forth below, and each Purchaser covenants that, except to the extent such restrictions are waived by the Company, it shall not transfer the Shares or the Warrant Shares represented by any
such certificate without complying with the restrictions on transfer described in this Agreement and the legend endorsed on such certificate: 

"THE
SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE
ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION UNDER SAID ACT AND, IF REQUESTED BY THE COMPANY, UPON DELIVERY OF AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT THE PROPOSED TRANSFER IS EXEMPT FROM SAID ACT." 

7.        Affirmative
Covenants of the Company. The Company hereby covenants and agrees that it will file a Preliminary Proxy Statement with the SEC as soon as possible after the Initial
Closing, containing, amongst other matters, a request for stockholder approval required under Rule 4350(i) of the Nasdaq Marketplace Rules for the transactions contemplated hereby. Upon
obtaining such stockholder approval, the shares of Series A Preferred Stock shall, by their terms, immediately convert into shares of Common Stock of the Company. 

        8.    Miscellaneous
Provisions. 

        8.1    Public Statements or Releases.    None of the parties to this Agreement shall make, issue, or release any
announcement, whether to the public generally, or to any of its suppliers or customers, with respect to this Agreement or the transactions provided for herein, or make any 

7

 

statement or acknowledgment of the existence of, or reveal the status of, this Agreement or the transactions provided for herein, without the prior consent of the other parties, which shall not be
unreasonably withheld or delayed, provided, that nothing in this Section 8.1 shall prevent any of the parties hereto from making such public announcements as it may consider necessary in order
to satisfy its legal obligations including the actions contemplated by the Registration Rights Agreement, but to the extent not inconsistent with such obligations, it shall provide the other parties
with an opportunity to review and comment on any proposed public announcement before it is made. The parties hereto agree that the Company may issue a press release in substance substantially as set
forth on Schedule 8.1 hereto. 

        8.2    Further Assurances.    Each party agrees to cooperate fully with the other party and to execute such further
instruments, documents and agreements and to give such further written assurances, as may be reasonably requested by the other party to better evidence and reflect the transactions described herein
and contemplated hereby, and to carry into effect the intents and purposes of this Agreement. 

        8.3    Rights Cumulative.    Each and all of the various rights, powers and remedies of the parties shall be
considered to be cumulative with and in addition to any other rights, powers and remedies which such parties may have at law or in equity in the event of the breach of any of the terms of this
Agreement. The exercise or partial exercise of any right, power or remedy shall neither constitute the exclusive election thereof nor the waiver of any other right, power or remedy available to such
party. 

        8.4    Pronouns.    All pronouns or any variation thereof shall be deemed to refer to the masculine, feminine or
neuter, singular or plural, as the identity of the person, persons, entity or entities may require. 

        8.5    Notices.    

	(a)
	Any
notices, reports or other correspondence (hereinafter collectively referred to as "correspondence") required or permitted to be given hereunder shall be sent by postage prepaid
first class mail, courier or telecopy or delivered by hand to the party to whom such correspondence is required or permitted to be given hereunder. The date of giving any notice shall be the date of
its actual receipt.

	(b)
	All
correspondence to the Company shall be addressed as follows: 

Tripath
Technology, Inc.

3900 Freedom Circle

Santa Clara, California 95054

Attention: John DiPietro

Telecopier: (408) 565-6824 

        with
a copy to: 

Gray
Cary Ware & Freidenrich LLP

400 Hamilton Avenue

Palo Alto, California 95054

Attention: John Fogg, Esq.

Telecopier: (650) 833-2001 

	(c)
	All
correspondence to the Purchasers shall be addressed to each Purchaser at the address set forth on Exhibit A hereto. 

8

 

	(d)
	Any
entity may change the address to which correspondence to it is to be addressed by notification as provided for herein. 

        8.6    Captions.    The captions and paragraph headings of this Agreement are solely for the convenience of reference
and shall not affect its interpretation. 

        8.7    Severability.    Should any part or provision of this Agreement be held unenforceable or in conflict with the
applicable laws or regulations of any jurisdiction, the invalid or unenforceable part or provisions shall be replaced with a provision which accomplishes, to the extent possible, the original business
purpose of such part or provision in a valid and enforceable manner, and the remainder of this Agreement shall remain binding upon the parties hereto. 

        8.8    Governing Law; Injunctive Relief.    

	(a)
	This
Agreement shall be governed by and construed in accordance with the internal and substantive laws of California and without regard to any conflicts of laws concepts which
concepts, which would apply the substantive law of some other jurisdiction.

	(b)
	Each
of the parties hereto acknowledges and agrees that damages will not be an adequate remedy for any material breach or violation of this Agreement if such material breach or
violation would cause immediate and irreparable harm (an "Irreparable Breach"). Accordingly, in the event of a threatened or ongoing Irreparable Breach, each party hereto shall be entitled to seek, in
any state or federal court in the State of California, equitable relief of a kind appropriate in light of the nature of the ongoing or threatened Irreparable Breach, which relief may include, without
limitation, specific performance or injunctive relief; provided, however, that if the party bringing such action is unsuccessful in obtaining the relief sought, the moving party shall pay the
non-moving party's reasonable costs, including attorney's fees, incurred in connection with defending such action. Such remedies shall not be the parties' exclusive remedies, but shall be
in addition to all other remedies provided in this Agreement. 

        8.9    Waiver.    No waiver of any term, provision or condition of this Agreement, whether by conduct or otherwise, in
any one or more instances, shall be deemed to be, or be construed as, a further or continuing waiver of any such term, provision or condition or as a waiver of any other term, provision or condition
of this Agreement. 

        8.10    Expenses.    Each party will bear its own costs and expenses in connection with this Agreement. 

        8.11    Assignment.    The rights and obligations of the parties hereto shall inure to the benefit of and shall be
binding upon the authorized successors and permitted assigns of each party. No Purchaser may assign its rights or obligations under this Agreement or designate another person (i) to perform all
or
part of its obligations under this Agreement or (ii) to have all or part of its rights and benefits under this Agreement, in each case without the prior written consent of the Company. The
Company may not assign its rights or obligations under this Agreement without the prior written consent of Purchasers holding a majority of the outstanding shares of Series A Preferred Stock.
In the event of any assignment in accordance with the terms of this Agreement, the assignee shall specifically assume and be bound by the provisions of the Agreement by executing and agreeing to an
assumption agreement reasonably acceptable to the other party. 

        8.12    Survival.    The respective representations and warranties given by the parties hereto, and the other
covenants and agreements contained herein, shall survive the Closing Date and the consummation of the transactions contemplated herein for a period of one year, without regard to any investigation
made by any party. 

9

 

        8.13    Entire Agreement.    This Agreement constitutes the entire agreement between the parties hereto respecting the
subject matter hereof and supersedes all prior agreements, negotiations, understandings, representations and statements respecting the subject matter hereof, whether written or oral. No modification,
alteration, waiver or change in any of the terms of this Agreement shall be valid or binding upon the parties hereto unless made in writing and duly executed by the Company and the Purchasers. 

        8.14    Counterparts.    This Agreement may be executed in a number of counterparts, each of which together, shall for
all purposes constitute one Agreement, binding on all of the parties hereto, notwithstanding that all such parties have not signed the same counterpart. 

        IN
WITNESS WHEREOF, the parties hereto have executed this Securities Purchase Agreement under seal as of the day and year first above written. 

	 	 	TRIPATH TECHNOLOGY, INC.
	

 	
 	

By:	
 	

/s/  DR. ADYA S. TRIPATHI      
 Dr. Adya S. Tripathi
 President and Chief Executive
Officer
	

 	
 	

 Signature of Purchaser
	

 	
 	

 Print Name of Purchaser

10

 
 
 

EXHIBIT A    
  

	Name
	 	Number of Units
	 	Total Purchase Price

	305 Investments, L.P.	 	3,500	 	$	105,000
	

AIG DKR Sound Shore

Holding Ltd	
 	

8,334	
 	
$	

250,020
	

Alpha Capital AG	
 	

10,000	
 	
$	

300,000
	

Jonathan Art	
 	

1,750	
 	
$	

52,500
	

Ascend Partners, LP	
 	

2,011	
 	
$	

60,330
	

Ascend Partners Sapient LP	
 	

2,955	
 	
$	

88,650
	

Ascend Offshore Fund Ltd	
 	

11,034	
 	
$	

331,020
	

Ben Joseph Partners	
 	

3,000	
 	
$	

90,000
	

Gregory J. Berlacher	
 	

1,000	
 	
$	

30,000
	

Robert A. Berlacher	
 	

1,250	
 	
$	

37,500
	

David Callan	
 	

4,000	
 	
$	

120,000
	

John Chong	
 	

1,000	
 	
$	

30,000
	

Circle T Partners	
 	

17,000	
 	
$	

510,000
	

Crossover Ventures, Inc.	
 	

20,000	
 	
$	

600,000
	

Encinal Partners	
 	

12,000	
 	
$	

360,000
	

Encinal Crossover Fund	
 	

3,000	
 	
$	

90,000
	

Endeavor Asset Management	
 	

10,000	
 	
$	

300,000
	

Jean Flax	
 	

1,000	
 	
$	

30,000
	

Keith Fretz	
 	

1,700	
 	
$	

51,000
	

William B. Fretz	
 	

1,000	
 	
$	

30,000
	

Bear Stearns Securities

Corp Custodian FBO

Constance Fretz IRA	
 	

1,000	
 	
$	

30,000
	

Bear Stearns Securities

Corp Custodian FBO W.

Bruce Fretz IRA	
 	

1,000	
 	
$	

30,000
	

Frorer Partners, L.P.	
 	

10,000	
 	
$	

300,000
	

Vincent J. Fumo	
 	

1,335	
 	
$	

40,050
	

Gruber & McBaine International	
 	

5,833	
 	
$	

174,990
	

Jon D. Gruber and Linda W. Gruber	
 	

5,000	
 	
$	

150,000
	

Jon D. Gruber TTEE

FBO Jonathan Wyatt

Gruber Dtd 12/30/75	
 	

833	
 	
$	

24,990  

11

 

	

Jon D. Gruber TTEE

FBOLindsay Gruber Dtd

12/29/76	
 	

833	
 	
$	

24,990
	

Gryphon Master Fund	
 	

16,667	
 	
$	

500,010
	

Insignia Partners, L.P.	
 	

2,500	
 	
$	

75,000
	

JEB Investments, Ltd.	
 	

20,000	
 	
$	

600,000
	

JEB Partners, L.P.	
 	

20,000	
 	
$	

600,000
	

Richard Johnson	
 	

500	
 	
$	

15,000
	

David and Debra Ann Johnson JT TEN	
 	

1,000	
 	
$	

30,000
	

Lancaster Investment Partners, L.P.	
 	

12,500	
 	
$	

375,000
	

Langley Partners, LP	
 	

8,500	
 	
$	

255,000
	

Lagunitas Partners, L.P.	
 	

27,500	
 	
$	

825,000
	

Manchester Growth Fund, L.P.	
 	

15,000	
 	
$	

450,000
	

Manchester Institution Fund, L.P.	
 	

25,000	
 	
$	

750,000
	

Manchester Offshore, Ltd.	
 	

20,000	
 	
$	

600,000
	

Stephen C. Marcus	
 	

1,000	
 	
$	

30,000
	

Stephen C. Marcus C/F

Shane Newman UGMA/PA	
 	

250	
 	
$	

7,500
	

Osirus Investment Partners, LP	
 	

5,000	
 	
$	

150,000
	

Pequot Scout Fund, L.P.	
 	

75,000	
 	
$	

2,250,000
	

Pequot Navigator Offshore Fund, Inc.	
 	

25,000	
 	
$	

750,000
	

Polar Capital, L.P.	
 	

17,000	
 	
$	

510,000
	

Porter Partners, L.P	
 	

10,000	
 	
$	

300,000
	

Prism Partners, L.P.	
 	

51,500	
 	
$	

1,545,000
	

Prism Offshore Fund Ltd	
 	

65,165	
 	
$	

1,954,950
	

Proximity Fund LP	
 	

10,000	
 	
$	

300,000
	

Proximity International Ltd.	
 	

3,333	
 	
$	

99,990
	

Quantico Partners, L.P.	
 	

8,500	
 	
$	

255,000
	

Sethuram Family Trust	
 	

5,000	
 	
$	

150,000
	

SF Capital Partners Ltd	
 	

33,334	
 	
$	

1,000,020
	

Ronald Spangler	
 	

1,666	
 	
$	

49,980
	

Spinner Global

Technology Fund, Ltd.	
 	

66,667	
 	
$	

2,000,010  

12

 

	

Peter G. Stanley TTEE

U/W/O Edward Stanley

FBO Peter G. Stanley

GST Exempt	
 	

5,500	
 	
$	

165,000
	

Peter G. Stanley TTEE

U/W/O Edward Stanley

FBO Peter G. Stanley

Non-Exempt	
 	

5,500	
 	
$	

165,000
	

 	
 	
699,950	
 	
$	

20,998,500.00

13

QuickLinks

SECURITIES PURCHASE AGREEMENT

EXHIBIT APrepared by MERRILL CORPORATION

QuickLinks
 -- Click here to rapidly navigate through this document
  

 
 

Exhibit 10.9    
  

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, ASSIGNED OR TRANSFERRED WITHOUT AN EFFECTIVE
REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, UNLESS THE COMPANY HAS RECEIVED THE WRITTEN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY TO THE EFFECT THAT
SUCH SALE, ASSIGNMENT OR TRANSFER DOES NOT INVOLVE A TRANSACTION REQUIRING REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT 1933, AS AMENDED.

 
 

CERTIFICATE FOR «Units» WARRANTS    
  

Issue
Date:        January 24, 2002 

 
 

TRIPATH TECHNOLOGY, INC.    
    
    WARRANT CERTIFICATE    
  

        THIS CERTIFIES that, as of January 24, 2002, «Subscriber» or its registered assigns is the registered holder (the "Holder") of the
number of warrants (the "Warrants") set forth above (subject to adjustment as provided in Section 10 hereof), each of which represents the right to purchase one fully paid and
non-assessable share of Series A Preferred Stock, par value $0.001 per share (the "Series A Preferred Stock"), of Tripath Technology, Inc., a Delaware corporation (the
"Company"), at the exercise price (the "Exercise Price") of $39.00 per share of Series A Preferred Stock, at any time prior to the Termination Date hereinafter referred to, by surrendering this
Warrant Certificate, with the form of
Election to Purchase set forth hereon duly executed, at the Company's office, and by paying in full the Exercise Price, plus transfer taxes, if any, in United States currency by certified check, bank
cashier's check or money order payable to the order of the Company. 

        These
Warrants have been issued concurrently with certain shares of the Company's Series A Preferred Stock pursuant to an effective Securities Purchase Agreement of even date
herewith between the Company and the Holder (the "Purchase Agreement"), and represent the right to purchase that number of shares of Series A Preferred Stock equal to twenty percent (20%) of
that number of shares of Series A Preferred Stock purchased by the Holder pursuant to the Securities Purchase Agreement. 

        1.    Exercise Period—The purchase rights represented by this Warrant are exercisable by the
Holder, in whole or in part, at any time and from time to time during the Exercise Period, which shall commence on the date hereof and shall end on the earlier of (i) 5:00 p.m. Eastern
Standard time on January 24, 2005 or (ii) a Change of Control (the "Termination Date"); provided, however, that should the Company fail to
provide notice of the Change of Control to the Holder as provided below, the Warrants shall not terminate on such Change of Control. For purposes of this Warrant, a Change of Control shall mean
(i) the consolidation of the Company with or merger of the Company with or into any other person in which the Company is not the surviving corporation and after which persons who were not
stockholders of the Company immediately prior to such merger or consolidation own immediately after such merger or consolidation 50% or more of the voting power of the outstanding securities of each
of the continuing or surviving entity and any direct or indirect parent corporation of such continuing or surviving entity, (ii) the sale of all or substantially all of the assets of the
Company to any other person, or (iii) any sale or transfer of any capital stock of the Company after the date of this Agreement, following which 50% of the combined voting power of the Company
becomes beneficially owned by one person or group acting together. The Company shall give written notice to each Holder at least fifteen (15) days prior to the date or expected date on which a
Change of Control 

1

 

is to be consummated. For purposes of this definition, "group" shall have the meaning as such term is used in Section 13(d)(1) under the Exchange Act. 

        2.    Exercise Price—The price per share of the Series A Preferred Stock at which
this Warrant may be exercised (the "Exercise Price") shall be $39.00 per share of Series A Preferred Stock, subject to adjustment as provided herein. 

        3.    Exercise of Warrant—During the Exercise Period, this Warrant may be exercised, in
whole or in part and from time to time, by the surrender of this Warrant and the Notice of Exercise annexed hereto duly executed at the principal office of the Company (or such other office or agency
of the Company as it may designate) and upon payment of the Exercise Price of the shares thereby purchased (the aggregate of the Exercise Price for all shares to be exercised being referred to herein
as the "Purchase Price"). Payment of the Purchase Price may be made (i) by check or bank draft payable to the order of t he Company or (ii) by wire transfer to the account of the
Company. Upon exercise, the Holder shall be entitled to receive, promptly after payment in full, one or more certificates, issued in the Holder's name or in such name or names as the Holder may
direct, subject to the limitations on transfer contained herein, for the number of shares of Series A Preferred Stock so purchased. The shares so
purchased shall be deemed to be issued as of the close of business on the date on which the Company receives the duly executed Notice of Exercise and the Purchase Price. 

        The
Company covenants that all shares of Series A Preferred Stock that are issued upon the exercise of rights represented by this Warrant will be fully paid, nonassessable, and
free from all taxes, liens and charges in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue). 

        4.    Mandatory Exercise—In the event that the sales price of the Company's Common Stock as
quoted on the Nasdaq National Market, or any other national securities exchange or automated quotation system, as they case may be, on which the Company's Common Stock is listed or trades, reaches
$5.85 per share or greater for twenty (20) days (which need not be consecutive) during any thirty (30) day period, then the Holder shall, within ten (10) days of receipt of notice
of the foregoing from the Company, be required to exercise the Warrant in full by paying to the Company the aggregate Purchase Price for the shares in accordance with the terms of Section 3
hereof. If the Holder does not exercise the Warrant in full within such time period, then the Warrant shall terminate and be cancelled without further action on the part of the Company or the Holder,
and the Holder shall have no further rights under the Warrant or to the shares issuable upon exercise of the Warrant. Notwithstanding the foregoing, in the event that the Company is unable to obtain
approval of the conversion of the Series A Preferred Stock by the holders of the Common Stock or the registration statement covering the resale of the shares underlying this Warrant is not
declared effective by the Securities and Exchange Commission, the Holder shall not be required to exercise the Warrant pursuant to this provision. 

        5.    No Fractional Shares or Scrip—No fractional shares or scrip representing fractional
shares shall be issued upon the exercise of this Warrant. In lieu thereof, a cash payment shall be made equal to such fraction multiplied by the Exercise Price per share as then in effect. 

        6.    Charges, Taxes and Expenses—Issuance of certificates for shares of Series A
Preferred Stock shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate; provided, however, that the Holder
shall be responsible for any issue or transfer tax associated with such issuance. 

        7.    No Rights as Shareholder—This Warrant does not entitle the Holder to any voting rights
or other rights as a shareholder of the Company prior to exercise and payment of the Exercise Price in accordance with Section 3 hereof. 

2

 

        8.    Investment Representation—The Holder (i) is an "Accredited Investor" as that
term is defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933, as amended, (the "Securities Act");
(ii) has the ability to bear the economic risks of such Holder's prospective investment, including a complete loss of Holder's investment in the Warrants and the shares of Series A
Preferred Stock issuable upon the exercise thereof (collectively, the "Securities"); (iii) has been furnished with and has had access to such information as such Holder has considered necessary
to make a determination as to the purchase of the Securities together with such additional information as is necessary to verify the accuracy of the information supplied; (iv) has had the
opportunity to ask questions concerning the Company and had all questions which have been asked by such Holder satisfactorily answered by the Company; and (v) has not been offered the
Securities by any form of advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or broadcast over television or radio, or any seminar or meeting
whose attendees have been invited by any such media. The Holder, by acceptance of this Warrant, represents and warrants to the Company that this Warrant and all securities acquired upon any and all
exercises of this Warrant are purchased for the Holder's own account for investment, and not with view to distribution of either this Warrant or any securities purchasable upon exercise hereof in
violation of the Securities Act. 

        9.    Listing, Exercise or Transfer Without Registration

        9.1  Listing—The Company shall promptly secure the listing of the shares of Common Stock
issuable upon conversion of the Series A Preferred Stock issuable upon exercise of the Warrant upon each national securities exchange or automated quotation system, if any, upon which shares of
Common Stock are then listed (subject to official notice of issuance upon exercise of this Warrant) and shall maintain, so long as any other shares of Common Stock shall be so listed, such listing of
all shares of Common Stock from time to time issuable upon the conversion of the Shares of Series A Preferred Stock issuable upon exercise of this Warrant; and the Company shall so list on each
national securities exchange or automated quotation system, as the case may be, and shall maintain such listing of, any other shares of capital stock of the Company issuable upon the exercise of this
Warrant if and so long as any shares of the same class shall be listed on such national securities exchange or automated quotation system. 

        9.2  Exercise or Transfer Without Registration—If, at the time of the surrender of this
Warrant in connection with any exercise, transfer, or exchange of this Warrant, this Warrant (or, in the case of any exercise, the shares of Series A Preferred Stock issuable hereunder), shall
not be registered under the Securities Act, and under applicable state securities or blue sky laws, the Company may require, as a condition of allowing such exercise, transfer, or exchange,
(i) that the holder or transferee of this Warrant, as the case may be, furnish to the Company a written opinion of counsel that is reasonably acceptable to the Company to the effect that such
exercise, transfer or exchange may be made without registration under the Securities Act and under applicable state securities or blue sky laws, (ii) that the holder or transferee execute and
deliver to the Company an investment letter in form and substance acceptable to the Company and (iii) that the transferee be an "accredited investor" as defined in Rule 501(a)
promulgated under the Securities Act; provided that no such opinion, letter or status as an "accredited investor" shall be required in connection with a transfer pursuant to Rule 144 under the
Securities Act. 

        9.3  Registration Rights. The Holder understands that neither the Warrant nor the shares of
Series A Preferred Stock issuable hereunder or the shares of Common Stock issuable upon conversion of the Series A Preferred Stock have been registered under the Securities Act. The
shares of Series A Preferred Stock issuable hereunder are entitled to the registration rights referred to in the Securities Purchase
Agreement dated as of January    , 2002 by and among the Company, the Holder and the other persons identified therein as Purchasers. 

3

 

        10.  Adjustments. The Exercise Price and the number and kind of securities purchasable hereunder are
subject to adjustment, as follows: 

      10.1  Conversion or Redemption of Series A Preferred Stock. Should all of the Company's
Series A Preferred Stock be, or if outstanding would be, at any time prior to the expiration of this Warrant or any portion thereof, redeemed or converted into shares of the Company's Common
Stock in accordance with the terms of the Certificate of Designations, then this Warrant shall become immediately exercisable for that number of shares of the Company's Common Stock equal to the
number of shares of the Common Stock that would have been received if this Warrant had been exercised in full and the Series A Preferred Stock received thereupon had simultaneously converted
immediately prior to such event, and the Exercise Price shall immediately be adjusted to equal the quotient obtained by dividing (x) the aggregate Exercise Price of the maximum number of shares
of Series A Preferred Stock for which this Warrant was exercisable immediately prior to such conversion or redemption, by (y) the number of shares of Common Stock for which this Warrant
is exercisable immediately after such conversion or redemption. For purposes of the foregoing, the "Certificate of Designations shall mean the Certificate of Incorporation of the Company as amended
and/or restated and effective immediately prior to the redemption or conversion of all of the Company's Series A Preferred Stock. 

      10.2  Reclassification of Shares. If the Company at any time shall, by combination, reclassification,
exchange or subdivision of securities or otherwise, change any of the securities as to which purchase rights under this Warrant Agreement exist into the same or a different number of securities of any
other class or classes, this Warrant Agreement shall thereafter represent the right to acquire such number and kind of securities as would have been issuable as the result of such change with respect
to the securities which were subject to the purchase rights under this Warrant Agreement immediately prior to such combination, reclassification, exchange, subdivision or other change. 

      10.3  Subdivision or Combination of Shares. If the Company at any time shall combine or subdivide the
securities as to which purchase rights under this Warrant exist, into a different number of securities of the same class, the Exercise Price shall be proportionately decreased in the case of a
subdivision, or proportionately increased in the case of a combination, and the number of shares available for purchase in effect immediately prior to such subdivision or combination shall be
proportionately adjusted. 

      10.4  Stock Dividends. If the Company at any time shall pay a dividend payable in, or make any other
distribution (except any distribution specifically provided for in the foregoing Sections 10.2 or 10.3) of, the Company's stock, then in each such case, the Holder, on exercise of this Warrant at any
time after
the consummation, effective date or record date of such event, shall receive, in addition to the shares or such other stock or securities issuable upon exercise prior to such date, the securities of
the Company to which the Holder would have been entitled upon such date if the Holder had exercised this Warrant immediately prior thereto (all subject to further adjustment as provided in this
Warrant). 

      10.5  Notice of Adjustment—In each case of any adjustment or readjustment in the
Series A Preferred Stock issuable upon the exercise of this Warrant, the Company at its expense will promptly compute such adjustment or readjustment in accordance with the terms of this
Warrant and prepare a report setting forth such adjustment or readjustment and showing in reasonable detail the method of calculation thereof and the facts upon such adjustment or readjustment is
based. The Company shall forthwith mail a copy of each such report to the Holder. 

      10.6  Notices of Record Date—In the event of any taking by the Company of a record of the
holders of any class of securities for the purpose of determining the holders thereof who are entitled to receive any dividend (other than a cash dividend that is the same as cash dividends paid 

4

 

in previous quarters) or other distribution, the Company shall mail to each Holder at least ten days prior to the date specified for the taking of a record, a notice specifying the date on which any
such record is to be taken for the purpose of such dividend or distribution. 

      10.7  Redemption of Preferred Stock—If the Company at any time is required to redeem
outstanding shares of Series A Preferred Stock pursuant to Section 5 of the Company's Certificate of Designation of Preferences and Rights of the Series A Preferred Stock dated
January 24, 2002, as the same may be amended from time to time in accordance therewith, the number of shares available for purchase under this Warrant in effect immediately prior to such
redemption ("Available Shares") shall be reduced, without additional consideration, to a number equal to the number of Available Shares multiplied by a fraction, the numerator being equal to the
number of shares of Series A Preferred Stock held by the original holder of this Warrant and its transferees immediately after redemption (not including any Warrant Shares issued upon exercise
of this Warrant) and the denominator being equal to the number of shares of Series A Preferred Stock initially purchased by such holder on the Issue Date of this Warrant under the Purchase
Agreement. If all of the shares of Series A Preferred Stock initially purchased by such holder on the Issue Date of this Warrant are redeemed, then this Warrant will be cancelled without
consideration and the Holder shall have no further rights hereunder. In no event shall the number of Available Shares be increased under this Section 10.7. 

        11.  Reservation of Stock Issuable on Exercise of Warrant—The Company will at all times
reserve and keep available, solely for issuance and delivery upon the exercise of this Warrant, all shares of Series A Preferred Stock from time to time issuable upon the exercise of this
Warrant and all shares of Common Stock issuable upon conversion of the Series A Preferred Stock issuable upon exercise of this Warrant. 

        12.  Loss, Theft, Destruction Mutilation of Warrant—Upon receipt by the Company of
evidence reasonably satisfactory to it of the loss, theft, destruction, or mutilation of this Warrant, and in case of loss, theft, or destruction, of indemnity or security reasonably satisfactory to
it, and upon reimbursement to the Company of all reasonable expenses incidental thereto, and upon surrender and cancellation of this Warrant, if mutilated, the Company will make and deliver a new
warrant of like tenor and dated as of such cancellation in lieu of this Warrant. 

        13.  Remedies—The Company stipulates that the remedies at law of the holder of this
Warrant in the event of any default or threatened default by the Company in the performance of or compliance with any of the terms of this Warrant are not adequate and may be enforced by a decree for
the specific performance of any agreement contained herein or by an injunction against a violation of any of the terms hereof or otherwise. 

        14.  Notices, etc.—All notices and other communications from the Company to the holder of
this Warrant shall be mailed, by first class mail or nationally recognized overnight courier such as Federal Express, to such address as may have been furnished to the Company in writing by such
holder, or, until an address is so furnished, to and at the address of the last holder of this Warrant who has so furnished an address to the Company. All communications from the holder of this
Warrant to the Company shall be mailed by first class mail or nationally recognized overnight courier such as Federal Express to the Company at it principal business address, or such other address as
may have been furnished to the holder in writing by the Company. 

        15.  Miscellaneous—This Warrant shall be construed and enforced in accordance with and
governed by the laws of the State of California without regard to principles of conflicts of law. The headings in this Warrant are for purposes of reference only, and shall not limit or otherwise
affect any of the terms hereof. This Warrant, or any portion hereof, may not, without the prior consent of the Company, be assigned at any time. 

5

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK] 

6

 

        IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed in its corporate name by its duly authorized officer and to be dated as of the issue date set forth on the first
page of this Warrant. 

	 	 	TRIPATH TECHNOLOGY, INC.
	

 	
 	

By:	
 	

 
	 	 	 	 	
 Dr. Adya S. Tripathi
 President and Chief Executive Officer

7

 
 
 

NOTICE OF EXERCISE OF WARRANT    
  

TO:        Tripath
Technology, Inc. 

                    Pursuant
to the terms of the attached Warrant, the undersigned hereby elects to purchase            shares of Series A Preferred Stock of Tripath
Technology, Inc. (the "Company"), and tenders herewith payment of the Exercise Price of such shares in full. 

        Please
issue a certificate or certificates representing said shares of Series A Preferred Stock, in the name of the undersigned or in such other name(s) as is/are specified
immediately below or, if necessary, on an attachment hereto: 

	 
	 	Name
	 	 
	 	Address

	
 	
 	

 	
 	

 	
 	

 
	DATE:	 	 	 	HOLDER:	 	 
	 	 	
	 	 	 	

	

DATE:	
 	

 	
 	

HOLDER:	
 	

 
	 	 	
	 	 	 	

8

QuickLinks

Exhibit 10.9

CERTIFICATE FOR «Units» WARRANTS

TRIPATH TECHNOLOGY, INC. WARRANT CERTIFICATE

NOTICE OF EXERCISE OF WARRANT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}]]